首页> 外文期刊>The aging male: the official journal of the International Society for the Study of the Aging Male >A herbal medicine, saikokaryukotsuboreito, improves serum testosterone levels and affects sexual behavior in old male mice
【24h】

A herbal medicine, saikokaryukotsuboreito, improves serum testosterone levels and affects sexual behavior in old male mice

机译:草药saikokaryukotsuboreito可改善老年雄性小鼠的血清睾丸激素水平并影响其性行为

获取原文
获取原文并翻译 | 示例
           

摘要

Late-onset hypogonadism (LOH) is a clinical syndrome characterized with aging and declined serum testosterone levels. Sexual symptoms are also essential for the diagnosis of LOH. Testosterone replacement therapy is used widely to treat LOH. However, the side effects of it should not be ignored, such as fluid retention, hypertension and spermatogenic suppression. Therefore, alternate treatment modalities have been pursued. Herbal medicines used widely in China have achieved satisfying results with little side effects. Nonetheless, there are few pharmacological researches on them. In this study, 24-month-old mice were used as LOH animal models to explore the pharmacological effects of a herbal medicine, saikokaryukotsuboreito (SKRBT), on serum testosterone levels and sexual functions. Furthermore, the expression of steroidogenic acute regulatory (StAR) protein, a kind of rate-limiting enzyme of testosterone synthesis, was also examined. As a result, SKRBT improved the serum testosterone levels of these mice at a dose of 300 and 450 mg/kg. Multiple measures of sexual behavior were enhanced. The expression of StAR was also increased. Therefore, this study suggested that SKRBT can improve the serum testosterone levels by activating the expression of StAR and might be a viable option to treat sexual symptoms caused by LOH.
机译:迟发性腺功能减退症(LOH)是一种临床综合征,其特征是衰老和血清睾丸激素水平下降。性症状对于LOH的诊断也至关重要。睾丸激素替代疗法被广泛用于治疗LOH。但是,它的副作用不容忽视,例如体液retention留,高血压和生精抑制。因此,已寻求替代治疗方式。在中国广泛使用的草药取得了满意的效果,几乎没有副作用。但是,关于它们的药理研究很少。在这项研究中,将24个月大的小鼠用作LOH动物模型,以探索草药saikokaryukotsuboreito(SKRBT)对血清睾丸激素水平和性功能的药理作用。此外,还检测了类固醇生成的急性调节(StAR)蛋白(一种睾丸激素合成的限速酶)的表达。结果,SKRBT以300和450 mg / kg的剂量改善了这些小鼠的血清睾丸激素水平。增强了对性行为的多种测量。 StAR的表达也增加。因此,这项研究表明,SKRBT可以通过激活StAR的表达来提高血清睾丸激素水平,并且可能是治疗由LOH引起的性症状的可行选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号